NRSN
Income statement / Annual
Last year (2025), NeuroSense Therapeutics Ltd's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, NeuroSense Therapeutics Ltd's net income was -$11.13 M.
See NeuroSense Therapeutics Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$89.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
-$89.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.23 M
|
$5.70 M
|
$7.27 M
|
$6.42 M
|
$3.08 M
|
$2.50 M
|
$898.00 K
|
| General & Administrative Expenses |
$4.86 M
|
$4.20 M
|
$4.78 M
|
$0.00
|
$2.51 M
|
$393.00 K
|
$337.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.86 M
|
$4.20 M
|
$4.78 M
|
$7.05 M
|
$2.51 M
|
$393.00 K
|
$337.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.09 M
|
$9.90 M
|
$12.05 M
|
$13.46 M
|
$5.59 M
|
$2.89 M
|
$1.24 M
|
| Cost And Expenses |
$11.09 M
|
$9.90 M
|
$12.05 M
|
$13.55 M
|
$5.59 M
|
$2.89 M
|
$1.24 M
|
| Interest Income |
$13.00 K
|
$2.00 K
|
$178.00 K
|
$91.00 K
|
$0.00
|
$61.00 K
|
$18.00 K
|
| Interest Expense |
$0.00
|
$311.00 K
|
$550.00 K
|
$15.00 K
|
$1.15 M
|
$0.00
|
$5.00 K
|
| Depreciation & Amortization |
$16.00 K
|
$22.00 K
|
$21.00 K
|
$89.00 K
|
$3.00 K
|
$3.00 K
|
$1.24 M
|
| EBITDA |
-$11.11 M |
-$9.88 M |
-$9.64 M |
-$12.23 M |
-$2.88 M |
-$2.83 M |
-$1.25 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$40.00 K
|
-$308.00 K
|
$1.94 M
|
$1.21 M
|
$1.55 M
|
$60.00 K
|
$13.00 K
|
| Income Before Tax |
-$11.13 M
|
-$10.21 M
|
-$10.11 M
|
-$12.34 M
|
-$4.04 M
|
-$2.83 M
|
-$1.22 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.13 M
|
-$10.21 M
|
-$10.11 M
|
-$12.34 M
|
-$4.04 M
|
-$2.83 M
|
-$1.23 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.44 |
-0.55 |
-0.83 |
-1.07 |
-0.23 |
-0.51 |
-0.22 |
| EPS Diluted |
-0.44 |
-0.55 |
-0.83 |
-1.07 |
-0.23 |
-0.51 |
-0.22 |
| Weighted Average Shares Out |
$25.48 M
|
$18.60 M
|
$13.64 M
|
$11.51 M
|
$10.86 M
|
$5.52 M
|
$5.45 M
|
| Weighted Average Shares Out Diluted |
$25.48 M
|
$18.60 M
|
$13.64 M
|
$11.51 M
|
$10.86 M
|
$5.52 M
|
$5.45 M
|
| Link |
|
|
|
|
|
|
|
